Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Explore the best cash back credit cards available to maximize your rewards and savings. Learn how to choose the right card for you.
28,074 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
When a giant like Verizon leaves the Dow, it can shake investor sentiment and fund flows. This guide explains why suc...
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
This analysis dives into the early 2026 earnings picture for J.Jill, unpacking revenue drivers, margin dynamics, and ...
When weighing broad tech exposure against a semiconductor tilt, Fidelity's ETF offers lower fees and wider reach. Lea...
As inflation data fuels debate, analysts clash on the 2027 Social Security COLA, with projections split between 3.8% ...
Home prices remain elevated while supply nudges higher. A new builders’ blueprint tackle housing outlines pragmatic s...
MoxiWorks unveils AI upgrades to its RISE platform, integrating marketing outreach with transaction tasks. Early clie...
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
Mortgage rates stay elevated due to tariff-driven inflation, delaying refinances and new purchases. The Fed has signa...